AsCNP/JSNP/JSCNP 2019

Presentation information

[AsCNP] Symposium

AsCNP » [AsCNP] Symposium

[AsCNP_S40] Symposium-40
Noteworthy drug discovery/research and development - Aiming for innovation -

Sun. Oct 13, 2019 8:40 AM - 10:20 AM Room 1 (Main Hall)

Organizer / Chair: Tetsurou KIKUCHI (New Drug Research Division, Pharmaceutical Business Division, Otsuka Pharmaceutical Co., Ltd.), Co-chair: George KOOB (National Institute on Alcohol Abuse and Alcoholism, USA)

9:17 AM - 9:26 AM

[AsCNP-S40-5] Study of ifenprodil effects on patients with methamphetamine dependence: study protocol for an exploratory randomized double-blind placebo-controlled trial

Toshihiko MATSUMOTO1, Hiroko KOTAJIMA-MURAKAMI1, 2, Ayumi TAKANO3, Yasukazu OGAI4, Daisuke FUNADA1, 5, Yuko TANIBUCHI1, 6, Hisateru TACHIMORI7, Kazushi MARUO8, Kazutaka IKEDA1, 2 (1. Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, 2. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 3. Department of Mental Health and Psychiatric Nursing Tokyo Medical and Dental University, 4. Social Psychiatry and Mental Health, Faculty of Medicine, University of Tsukuba, 5. Department of Psychiatry, Center Hospital, National Center of Neurology and Psychiatry, 6. Department of Psychiatry, Chiba Hospital, 7. Department of Clinical Research Promotion, Transrational Medical Center, National Center of Neurology and Psychiatry, 8. Department of Biostatistics, Faculty of Medicine, University of Tsukuba)

Abstract password authentication.
Password to browse/download the abstracts has been sent to pre-registrants by email and printed on name badge. It is also indicated in the abstract booklet.

Password